| Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion | Insider und/oder position |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Wert | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-08-26 | 2025-08-25 | K Kauf |
Chief Executive Officer (CEO)/Managing Directory Führungsperson |
49.379
183,43
4.980.909 SEK |
49.379 | 183,43 | 4.980.909 SEK | |
| 2025-08-01 | 2025-07-30 | K Kauf |
Other member of the company's administrative, management or supervisory body |
87.840
453,36
1.919.422 SEK |
87.840 | 453,36 | 1.919.422 SEK | |
| 2025-07-29 | 2025-07-29 | K Kauf |
Chief Executive Officer (CEO)/Managing Directory Führungsperson |
89.430
379,34
3.478.928 SEK |
89.430 | 379,34 | 3.478.928 SEK | |
| 2025-07-28 | 2025-07-28 | K Kauf |
Other member of the company's administrative, management or supervisory body |
4.545
2,20
9.999 SEK |
4.545 | 2,20 | 9.999 SEK | |
| 2025-07-27 | 2025-07-25 | K Kauf |
Chief Executive Officer (CEO)/Managing Directory Führungsperson |
178.549
2,20
392.808 SEK |
178.549 | 2,20 | 392.808 SEK | |
| 2025-07-31 | 2025-07-24 | K Kauf |
Member of the Board of Directors Verwaltungsratsmitglied |
150.000
2,20
330.000 SEK |
150.000 | 2,20 | 330.000 SEK | |
| 2025-07-26 | 2025-07-23 | K Kauf |
Other senior executive Führungsperson |
22.727
2,20
49.999 SEK |
22.727 | 2,20 | 49.999 SEK | |
| 2025-07-25 | 2025-07-23 | K Kauf |
Chairman of the Board of Directors Verwaltungsratsmitglied |
568.030
2,20
1.249.666 SEK |
568.030 | 2,20 | 1.249.666 SEK | |
| 2025-07-26 | 2025-07-17 | V Verkauf |
Other senior executive Führungsperson |
500.000
0,15
75.000 SEK |
500.000 | 0,15 | 75.000 SEK | |
| 2025-07-26 | 2025-07-17 | V Verkauf |
Other senior executive Führungsperson |
500.000
0,15
75.000 SEK |
500.000 | 0,15 | 75.000 SEK | |
| 2024-05-29 | 2024-05-28 | K Kauf |
Chief Executive Officer (CEO)/Managing Directory Führungsperson |
100.000
1,70
170.000 SEK |
100.000 | 1,70 | 170.000 SEK | |
| 2024-05-23 | 2024-05-20 | K Kauf |
Member of the Board of Directors Verwaltungsratsmitglied |
12.500
1,70
21.250 SEK |
12.500 | 1,70 | 21.250 SEK | |
| 2024-05-24 | 2024-05-17 | K Kauf |
Other member of the company's administrative, management or supervisory body |
37.083
1,70
63.041 SEK |
37.083 | 1,70 | 63.041 SEK | |
| 2024-05-21 | 2024-05-17 | K Kauf |
Chief Executive Officer (CEO)/Managing Directory Führungsperson |
121.433
1,70
206.436 SEK |
121.433 | 1,70 | 206.436 SEK | |
| 2024-05-21 | 2024-05-17 | K Kauf |
Chief Executive Officer (CEO)/Managing Directory Führungsperson |
83.300
1,70
141.610 SEK |
83.300 | 1,70 | 141.610 SEK | |
| 2024-05-21 | 2024-05-17 | K Kauf |
Other member of the company's administrative, management or supervisory body |
44.500
1,70
75.650 SEK |
44.500 | 1,70 | 75.650 SEK | |
| 2024-05-20 | 2024-05-17 | K Kauf |
Member of the Board of Directors Verwaltungsratsmitglied |
12.500
1,70
21.250 SEK |
12.500 | 1,70 | 21.250 SEK | |
| 2024-05-20 | 2024-05-17 | K Kauf |
Chairman of the Board of Directors Verwaltungsratsmitglied |
320.833
1,70
545.416 SEK |
320.833 | 1,70 | 545.416 SEK | |
| 2024-05-20 | 2024-05-17 | K Kauf |
Chairman of the Board of Directors Durch Oncolution AB, eine nahestehende Person Verwaltungsratsmitglied |
429.813
1,70
730.682 SEK |
429.813 | 1,70 | 730.682 SEK | |
| 2024-05-20 | 2024-05-17 | K Kauf |
Chief Financial Officer (CFO) Durch Enable - Finance & Business Development in Sweden AB, eine nahestehende Person Führungsperson |
8.750
1,70
14.875 SEK |
8.750 | 1,70 | 14.875 SEK |
Weitere Insiderhandel-Analysen zu AlzeCure Pharma AB